Nuance Investments LLC Boosts Holdings in The Clorox Company $CLX

Nuance Investments LLC grew its position in shares of The Clorox Company (NYSE:CLX) by 13.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 786,789 shares of the company’s stock after buying an additional 91,972 shares during the period. Clorox makes up 8.7% of Nuance Investments LLC’s holdings, making the stock its biggest position. Nuance Investments LLC’s holdings in Clorox were worth $79,332,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in CLX. Center for Financial Planning Inc. bought a new position in Clorox during the 3rd quarter worth $25,000. Vermillion & White Wealth Management Group LLC bought a new position in Clorox during the 3rd quarter worth $25,000. Darwin Wealth Management LLC bought a new position in Clorox during the 2nd quarter worth $29,000. Vision Financial Markets LLC increased its position in shares of Clorox by 166.7% in the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares during the period. Finally, Ameriflex Group Inc. increased its position in shares of Clorox by 1,436.8% in the third quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock worth $36,000 after purchasing an additional 273 shares during the period. Institutional investors own 78.53% of the company’s stock.

Insider Activity at Clorox

In other news, Director Pierre R. Breber purchased 5,000 shares of the company’s stock in a transaction dated Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.63% of the stock is owned by corporate insiders.

Clorox Price Performance

Shares of NYSE:CLX opened at $94.07 on Friday. The stock’s 50 day moving average is $96.95 and its 200-day moving average is $105.31. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $132.03. The firm has a market capitalization of $11.37 billion, a price-to-earnings ratio of 15.27, a PEG ratio of 0.46 and a beta of 0.56. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.Clorox’s revenue was up .1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Sell-side analysts forecast that The Clorox Company will post 5.61 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CLX. Wall Street Zen upgraded Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Wells Fargo & Company cut their price target on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, May 18th. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $83.00 price objective on shares of Clorox in a research note on Friday, May 1st. JPMorgan Chase & Co. cut their price objective on Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. Finally, BNP Paribas Exane cut their price objective on Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 12th. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat.com, Clorox currently has a consensus rating of “Reduce” and an average target price of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.